Published in Clin Microbiol Infect on August 01, 2007
Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother (2008) 3.24
Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis (2010) 2.58
Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother (2011) 2.09
OXA β-lactamases. Clin Microbiol Rev (2014) 1.95
Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.89
Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci U S A (2011) 1.72
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J Clin Microbiol (2009) 1.71
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.64
OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.62
Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol (2010) 1.59
AbaR5, a large multiple-antibiotic resistance region found in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.57
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob Agents Chemother (2008) 1.57
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. Antimicrob Agents Chemother (2011) 1.27
AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments. MBio (2014) 1.26
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother (2010) 1.23
Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob Agents Chemother (2012) 1.18
Use of the accessory genome for characterization and typing of Acinetobacter baumannii. J Clin Microbiol (2011) 1.16
Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II. Antimicrob Agents Chemother (2012) 1.14
Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol (2011) 1.12
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol (2010) 1.10
Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J Clin Microbiol (2012) 1.10
Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England. Genome Med (2014) 1.10
Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J Antimicrob Chemother (2011) 1.06
Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One (2012) 1.03
Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol (2009) 1.02
Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. BMC Genomics (2014) 1.01
Identification of a marker for two lineages within the GC1 clone of Acinetobacter baumannii. J Antimicrob Chemother (2013) 1.00
Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2008) 0.98
Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PLoS One (2013) 0.98
Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother (2013) 0.98
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob Agents Chemother (2012) 0.97
Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol (2010) 0.97
Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol (2009) 0.95
Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol (2012) 0.94
Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother (2013) 0.93
Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey. J Clin Microbiol (2014) 0.93
Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia. Antimicrob Agents Chemother (2012) 0.92
Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages. J Clin Microbiol (2014) 0.92
Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii. Curr Microbiol (2011) 0.90
Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob Agents Chemother (2014) 0.90
Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities. J Clin Microbiol (2011) 0.89
Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion. Infect Genet Evol (2013) 0.87
Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrob Agents Chemother (2011) 0.84
Pan-PCR, a computational method for designing bacterium-typing assays based on whole-genome sequence data. J Clin Microbiol (2012) 0.83
Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit. Eur J Clin Microbiol Infect Dis (2015) 0.83
Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. J Clin Microbiol (2009) 0.82
Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS One (2014) 0.81
Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa. Eur Biophys J (2011) 0.80
Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol (2015) 0.80
Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of Acinetobacter baumannii in China. J Clin Microbiol (2013) 0.80
First Description of Two Sequence Type 2 Acinetobacter baumannii Isolates Carrying OXA-23 Carbapenemase in Pagellus acarne Fished from the Mediterranean Sea near Bejaia, Algeria. Antimicrob Agents Chemother (2016) 0.79
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect Dis (2015) 0.79
Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore. J Antimicrob Chemother (2017) 0.78
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit. BMC Infect Dis (2015) 0.78
Carbapenem-resistant Acinetobacter baumannii from Serbia: revision of CarO classification. PLoS One (2015) 0.78
Unsuitability of MALDI-TOF MS to discriminate Acinetobacter baumannii clones under routine experimental conditions. Front Microbiol (2015) 0.78
Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea. Ann Lab Med (2013) 0.77
Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates. Front Public Health (2016) 0.76
Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010. Eur J Clin Microbiol Infect Dis (2013) 0.76
New PCR-based open reading frame typing method for easy, rapid, and reliable identification of Acinetobacter baumannii international epidemic clones without performing multilocus sequence typing. J Clin Microbiol (2014) 0.75
Draft genome sequence of a multidrug-resistant Acinetobacter baumannii ST15 (CC15) isolated from Brazil. Mem Inst Oswaldo Cruz (2015) 0.75
Whole-Genome Sequencing Elucidates Epidemiology of Nosocomial Clusters of Acinetobacter baumannii. J Clin Microbiol (2016) 0.75
Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA. BMC Infect Dis (2016) 0.75
The Prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran. Jundishapur J Microbiol (2015) 0.75
AbaR7, a genomic resistance island found in multidrug-resistant Acinetobacter baumannii isolates in Daejeon, Korea. Ann Lab Med (2012) 0.75
Problems with the Oxford Multilocus Sequence Typing Scheme for Acinetobacter baumannii: Do Sequence Type 92 (ST92) and ST109 Exist? J Clin Microbiol (2017) 0.75
Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity. Front Cell Infect Microbiol (2016) 0.75
Resistance and integron characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China. New Microbes New Infect (2015) 0.75
Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital. PLoS One (2017) 0.75
Molecular characterization and genetic relatedness of clinically Acinetobacter baumanii isolates conferring increased resistance to the first and second generations of tetracyclines in Iran. Ann Clin Microbiol Antimicrob (2017) 0.75
Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J Clin Microbiol (1998) 5.38
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol (1996) 3.52
Imported melioidosis in England and Wales. Lancet (1999) 3.42
Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol (2005) 2.95
The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol (1973) 2.61
Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother (1998) 2.51
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun (1984) 2.39
Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol (1993) 2.38
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J Gen Virol (1974) 2.23
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. J Clin Microbiol (1991) 2.06
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol (1995) 1.87
Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit. J Antimicrob Chemother (1998) 1.77
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol (2004) 1.77
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71
Latex agglutination test for identification of Pseudomonas pseudomallei. J Clin Pathol (1993) 1.67
Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol (1996) 1.60
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol (1996) 1.52
Burkholderia pseudomallei and Indian plague-like illness. Lancet (1995) 1.44
Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect (2001) 1.42
Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1997) 1.38
Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol (1993) 1.37
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37
A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.34
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect (1995) 1.31
The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J Med Microbiol (1978) 1.29
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Lond) (1980) 1.24
Rapid and accurate identification of coagulase-negative staphylococci by real-time PCR. J Clin Microbiol (2001) 1.23
Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol (1986) 1.23
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol (1996) 1.22
Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis (2002) 1.22
Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem (1992) 1.22
Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.22
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett (1992) 1.21
New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. J Clin Microbiol (1987) 1.17
Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax (2002) 1.14
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect (1999) 1.14
PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. J Med Microbiol (1985) 1.12
Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med (1986) 1.12
O serotyping scheme for Enterobacter cloacae. J Clin Microbiol (1983) 1.12
An outbreak of melioidosis in imported primates in Britain. Vet Rec (1992) 1.11
State of the art: typing Pseudomonas aeruginosa. J Hosp Infect (1980) 1.11
Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol (1997) 1.08
Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop Med Int Health (1998) 1.08
Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J Clin Pathol (1995) 1.05
Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Infect (1992) 1.04
Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosa. J Med Microbiol (1986) 1.04
A comparison of typing methods for Serratia marcescens. J Hyg (Lond) (1977) 1.02
Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. J Hosp Infect (1997) 1.02
Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London. J Hosp Infect (2006) 1.01
Enterobacter cloacae in a neonatal intensive care unit: account of an outbreak and its relationship to use of third generation cephalosporins. J Hosp Infect (1994) 1.01
Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. Clin Microbiol Infect (2009) 1.00
A method for the detection of gelatinase production by bacteria. J Appl Bacteriol (1970) 1.00
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J Med Microbiol (1994) 1.00
Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli. J Clin Pathol (1999) 1.00
Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2008) 0.98
Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens. Epidemiol Infect (1993) 0.98
Infection with netilmicin resistant Serratia marcescens in a special care baby unit. Br Med J (Clin Res Ed) (1983) 0.98
Molecular typing of Myroides odoratimimus (Flavobacterium odoratum) urinary tract infections in a Turkish hospital. Eur J Clin Microbiol Infect Dis (2000) 0.96
An immunological study of the pili of Pseudomonas aeruginosa. J Hyg (Lond) (1975) 0.94
Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults. J Infect (1998) 0.94
Imipenem resistance in Proteus mirabilis. J Antimicrob Chemother (1991) 0.94
European-wide distribution of Pseudomonas aeruginosa clone C. Clin Microbiol Infect (2003) 0.93
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros (2007) 0.93
O-antigen specificities of the serotype strains of Serratia marcescens. J Clin Microbiol (1989) 0.93
Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Thorax (1992) 0.92
Rapid extraction of high purity chromosomal DNA from Serratia marcescens. Lett Appl Microbiol (1993) 0.92
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes. J Immunol (1991) 0.91
Pseudomonas aeruginosa colonisation in an intensive therapy unit: role of cross infection and host factors. Br Med J (Clin Res Ed) (1983) 0.91
Lipopolysaccharide profile typing as a technique for comparative typing of gram-negative bacteria. J Clin Microbiol (1993) 0.91
Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping. J Infect (1993) 0.91
Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera. Eur J Clin Microbiol (1985) 0.91
Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. J Clin Pathol (1986) 0.90
Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. J Med Microbiol (2000) 0.90
State of the art: typing of Serratia marcescens. J Hosp Infect (1982) 0.90
Bacterial typing systems: the way ahead. J Med Microbiol (1994) 0.90
State of the art in typing: Klebsiella spp. J Hosp Infect (1990) 0.90
Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance. J Med Microbiol (1991) 0.90
Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin Microbiol Infect (2009) 0.90